Amplification of KCNMA 1 : A Potential Therapeutic Target in Prostate Cancer


Prostate cancer is the most common cancer in males and the second leading cause of cancer deaths in western countries. Although most prostate cancers initially respond well to androgen withdrawal, they become inevitably resistant to this treatment and progress to hormone-insensitive disease after only a few months or years. The therapeutic options in these… (More)

11 Figures and Tables


  • Presentations referencing similar topics